Prevalence higher for current depressive symptoms and current anxiety symptoms
Participants with LLMDs more likely to be tau PET- and amyloid β PET-positive compared with healthy controls
Associations generally stronger for postnatal than antenatal mental distress
Findings seen for both suicide and overall mortality, with even stronger effects seen in more recent studies
About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy
Shorter leukocyte telomere length linked to higher incidence rates of stroke, dementia, late-life depression as composite and individually
Patients who start attending services a year or more after stroke less likely to recover from symptoms of depression, anxiety
Calorie-restricted, nutrient-restricted diets linked to increase in PHQ-9 depressive symptom severity scores in individuals with overweight
However, variability seen across clinic team members and lower reach among older and non-White patients
Depression present in late life and midlife linked to significantly increased risk for all-cause dementia